A collaboration among interventional oncologists pooling outcomes of 155 patients with neuroendocrine tumor liver metastases treated at seven cancer centers across the United States has won the CVIR Award for most highly cited article at the 2018 CIRSE Annual Meeting in Lisbon, Portugal.
Controversy erupted at the HCC Evidence-based Practice Debates at WCIO 2016 regarding combination therapy for HCC. Panelist, expert and author Karen Brown, MD from Memorial Sloan-Kettering Cancer Center responds:
It was an exciting day at the Suzhou International Expo Center, where the 12th Asia-Pacific Congress of Cardiovascular & interventional Radiology (APCCVIR 2016) hosted joint sessions with SIR, CIRSE and WCIO.
As trainees, we only see a small part of the process of treating any individual patient, usually at the stage of administering locoregional therapy in interventional radiology. In this setting, it can be difficult to fully understand the role of IR within the larger picture of multidisciplinary care
As Interventional Oncologists, we live in the Valley of the Shadow of Death. Contrary to Psalm 23, there is plenty for the wise practitioner to fear.